Virological and immunological efficacy of metabolically favorable antiretroviral therapy regimens in HIV patients who had no previous treatment-Reference-Cited by-同舟云学术

Virological and immunological efficacy of metabolically favorable antiretroviral therapy regimens in HIV patients who had no previous treatment

Published:2020-06-03 Issue:5 Volume:98 Page:24-31
ISSN:2542-1506
Container-title:Tuberculosis and Lung Diseases
language:
Short-container-title:Tuberk. bolezni lëgk.

Author:

Veselova E. I.¹,Kocharyan K. A.¹,Lovacheva O. V.¹,Kaminskiy G. D.¹,Samoylova A. G.¹,Vasilyeva I. A.¹

Affiliation:

1. National Medical Research Center of Phthisiopulmonology and Infectious Diseases

Publisher

New Terra

Subject

General Medicine

Reference17 articles.

1. Veselova E.I., Kaminskiy G.D., Samoylova А.G., Vasilyeva I.А. HIV reservoir in HIV patients. Tuberculosis and Lung Diseases, 2019, vol. 97, no. 5, pp. 50-57. (In Russ.)

2. Voronin E.E., Аfonina L.Yu., Rozenberg V.Ya., Latysheva I.B., Kaminskiy G.D., Bulankov Yu.I., Melnikova T.N., Radzikhovskaya M.V., Fomin Yu.А. VICH-infektsiya u vzroslykh: klinicheskie rekomendatsii. [HIV infection in adults: clinical guidelines]. 2017, 64 p.

3. Rukovodstvo o vremeni naznacheniya antiretrovirusnoy terapii i po dokontaktnoy profilaktike VICH-infektsii. [Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV]. WHO, 2015, 78 p.

4. Casado J.L., Monsalvo M., Rojo A.M., Fontecha M., Rodriguez-Sagrado M.A. Dolutegravir and rilpivirine for the maintenance treatment of virologically suppressed HIV-1 infection. Expert. Rev. Clin. Pharmacol., 2018, vol. 11, no. 6, pp. 561-570.

5. Cunha J., Maselli L.M.F., Bassi Stern A.C., Spada C., Bydlowski S.P. Impact of antiretroviral therapy on lipid metabolism of human immunodeficiency virus-infected patients: Old and new drugs. World J. Virol., 2015, vol. 4, no. 2, pp. 56-77.